AKT1 and Alzheimer disease: De la Monte et al. [58,73] observed decreased mRNA/protein expression of insulin receptors, insulin-like growth factors (IGF1 and IGF2), IRS1, PI3K/Akt as well as increased GSK-3β level in the post-mortem brains from AD patients.